Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Anales del Sistema Sanitario de Navarra
versión impresa ISSN 1137-6627
Resumen
ARIAS-DE LA VEGA, Fernando et al. Paraneoplastic hemolytic anemia associated with prostate cancer. A case report. Anales Sis San Navarra [online]. 2022, vol.45, n.3, e1023. Epub 24-Abr-2023. ISSN 1137-6627. https://dx.doi.org/10.23938/assn.1023.
Paraneoplastic syndromes are a group of tumor-related symptoms not directly attributable to tumors or metastasis. Symptoms are caused by secretion of substances by the tumor or the production of antibodies from immune cross-reactivity between tumor and normal tissues. Among hematological paraneoplastic syndromes, cancer-associated hemolytic anemias associated are rare, particularly in solid tumors.
We present the case of a patient with localized bladder (high-grade infiltrating papillary carcinoma pT1) and prostate (Gleason 7) cancer who developed warm antibody autoimmune hemolytic anemia during radiation therapy for prostate cancer. It was resolved with prednisone (1 mg/Kg/day, tapering schedule). To the best of our knowledge, this is the first time an autoimmune hemolytic anemia is described in the literature as a paraneoplastic syndrome in such early stages of tumor disease.
Palabras clave : Prostate cancer; Paraneoplastic; Anemia; Autoimmune; Hemolysis.